These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 2922083)
1. [The administration of calcium channel blockers in patients with cerebrovascular diseases]. Keppel Hesselink JM Ned Tijdschr Geneeskd; 1989 Jan; 133(4):180-1. PubMed ID: 2922083 [No Abstract] [Full Text] [Related]
2. Use of calcium channel blockers in acute ischemic cerebrovascular disease. Sood AK; Dua A; Mahajan A; Arora S J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106 [No Abstract] [Full Text] [Related]
3. [The use of nimodipine in comatose patients with different types of cerebrovascular pathology]. Alia G; Mattaliano A Clin Ter; 1993 Oct; 143(4):295-301. PubMed ID: 8258263 [TBL] [Abstract][Full Text] [Related]
4. [The use of the preparation Nimotop in neurosurgical patients]. Amcheslavskiĭ VG; Demchuk ML; Madorskiĭ SV; Toma GI; Margishvili GM; Fokin MS; Savin IA Zh Vopr Neirokhir Im N N Burdenko; 1997; (3):41-3. PubMed ID: 9424955 [No Abstract] [Full Text] [Related]
5. Use of calcium channel blockers in acute ischemic cerebrovascular disease. Dalal PM; Dalal KP J Assoc Physicians India; 1995 Jun; 43(6):394-7. PubMed ID: 8906943 [TBL] [Abstract][Full Text] [Related]
6. [Nervous disease & Ca antagonist]. Otomo E No To Shinkei; 1990 Jan; 42(1):33-41. PubMed ID: 2337488 [No Abstract] [Full Text] [Related]
8. From pharmacological promises to controlled clinical trials to meta-analysis and back: the case of nimodipine in cerebrovascular disorders. Di Mascio R; Marchioli R; Tognoni G Clin Trials Metaanal; 1994 Apr; 29(1):57-79. PubMed ID: 10150186 [TBL] [Abstract][Full Text] [Related]
9. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies. Tomassoni D; Lanari A; Silvestrelli G; Traini E; Amenta F Clin Exp Hypertens; 2008 Nov; 30(8):744-66. PubMed ID: 19021025 [TBL] [Abstract][Full Text] [Related]
10. Correlation between predicted theoretical mechanistic biochemistry (TMB) data and therapeutic effects in the management of vascular disorders with calcium channel blockers. Akintonwa DA; Odigwe CO Med Hypotheses; 2000 Jun; 54(6):944-7. PubMed ID: 10867744 [TBL] [Abstract][Full Text] [Related]
11. [Effect of nimodipine on the intracellular calcium level and platelet aggregation in ischemic stroke patients]. Prianikova NA; Dukhanin AS; Stakhovskaia LV; Chekneva NS Biull Eksp Biol Med; 1996 Mar; 121(3):317-20. PubMed ID: 8688539 [No Abstract] [Full Text] [Related]
12. [Effects of nimodipine on mental deterioration in subjects with chronic cerebrovascular pathology]. Canadè V; Catapano F; Muraca L; Cosentino A Minerva Med; 1991 Mar; 82(3):111-4. PubMed ID: 2006028 [TBL] [Abstract][Full Text] [Related]
13. The role of calcium antagonists in the treatment of cerebrovascular disease. Murphy JJ Drugs Aging; 1992; 2(1):1-6. PubMed ID: 1554969 [No Abstract] [Full Text] [Related]
14. Treating ischemic stroke: is nimodipine the answer? Ernst E Clin Pharm; 1992 Apr; 11(4):350-1. PubMed ID: 1563232 [No Abstract] [Full Text] [Related]
16. Prior calcium-channel antagonist use and ischemic stroke outcomes. Welty TE Ann Pharmacother; 1994 May; 28(5):671. PubMed ID: 8069009 [No Abstract] [Full Text] [Related]
17. [Nimodipine in ischemic cerebropathy]. Di Lascio G; Salvini S Clin Ter; 1993 Feb; 142(2):123-6. PubMed ID: 8472525 [TBL] [Abstract][Full Text] [Related]
18. [Calcium channel blockers in therapy of neurologic diseases]. Wessely P; Wöber-Bingöl C Wien Med Wochenschr; 1993; 143(19-20):514-8. PubMed ID: 8135034 [TBL] [Abstract][Full Text] [Related]